X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1816) 1816
Book Review (207) 207
Publication (168) 168
Book Chapter (9) 9
Dissertation (5) 5
Conference Proceeding (2) 2
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1485) 1485
humans (1467) 1467
cyp2c9 (1032) 1032
cytochrome p-450 cyp2c9 (917) 917
genotype (878) 878
male (856) 856
pharmacology & pharmacy (828) 828
female (823) 823
aryl hydrocarbon hydroxylases - genetics (800) 800
pharmacogenetics (744) 744
warfarin (744) 744
middle aged (627) 627
adult (547) 547
aged (494) 494
cytochrome p-450 (483) 483
polymorphism, genetic (435) 435
alleles (407) 407
vkorc1 (407) 407
warfarin - administration & dosage (389) 389
anticoagulants - administration & dosage (384) 384
polymorphism (376) 376
metabolism (375) 375
genetic aspects (357) 357
mixed function oxygenases - genetics (343) 343
genetic polymorphisms (294) 294
vitamin k epoxide reductases (287) 287
pharmacokinetics (270) 270
polymorphisms (270) 270
polymorphism, single nucleotide (269) 269
cytochrome p-450 enzyme system - genetics (267) 267
dose-response relationship, drug (265) 265
cytochrome p-450 cyp2c9 - genetics (262) 262
cytochrome p4502c9 (231) 231
gene frequency (229) 229
analysis (222) 222
aryl hydrocarbon hydroxylases - metabolism (220) 220
association (216) 216
aged, 80 and over (213) 213
anticoagulants (209) 209
research (205) 205
international normalized ratio (204) 204
population (201) 201
therapy (194) 194
algorithms (186) 186
anticoagulation (183) 183
anticoagulants - pharmacokinetics (174) 174
warfarin - pharmacokinetics (172) 172
young adult (171) 171
genetics & heredity (169) 169
adolescent (168) 168
hematology (166) 166
anticoagulants - therapeutic use (165) 165
variants (165) 165
physiological aspects (162) 162
vitamin k epoxide reductases - genetics (162) 162
abridged index medicus (161) 161
warfarin - therapeutic use (161) 161
dosage and administration (159) 159
risk (155) 155
cytochrome p450 (149) 149
pharmacogenomics (148) 148
pharmacology (148) 148
in-vitro (147) 147
anticoagulants - adverse effects (144) 144
cytochrome p-450 cyp2c19 (144) 144
enzymes (141) 141
genetic variation (139) 139
dose requirements (138) 138
cyp2c19 (134) 134
warfarin - adverse effects (133) 133
genes (131) 131
peripheral vascular disease (131) 131
phenotype (129) 129
asian continental ancestry group - genetics (126) 126
genotypes (124) 124
health aspects (124) 124
polymerase chain reaction (124) 124
risk factors (124) 124
cytochrome p-450 enzyme system - metabolism (119) 119
sensitivity (117) 117
acenocoumarol (116) 116
polymorphism, genetic - genetics (115) 115
drug metabolism (112) 112
pharmacology/toxicology (111) 111
phenytoin (110) 110
aryl hydrocarbon hydroxylases (109) 109
drug interactions (107) 107
genetics (107) 107
k epoxide reductase (105) 105
steroid 16-alpha-hydroxylase (103) 103
african-americans (102) 102
bleeding complications (102) 102
drugs (101) 101
drug therapy (100) 100
genetic-polymorphism (100) 100
cohort studies (97) 97
haplotypes (97) 97
genetic polymorphism (96) 96
genotype & phenotype (96) 96
article (95) 95
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1767) 1767
Russian (15) 15
French (11) 11
Japanese (10) 10
Chinese (9) 9
Spanish (7) 7
German (3) 3
Croatian (1) 1
Czech (1) 1
Dutch (1) 1
Hungarian (1) 1
Korean (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinica Chimica Acta, ISSN 0009-8981, 11/2011, Volume 412, Issue 23-24, pp. 2063 - 2069
Journal Article
THROMBOSIS AND HAEMOSTASIS, ISSN 0340-6245, 09/2007, Volume 98, Issue 3, pp. 570 - 578
For decades coumarins have been the most commonly prescribed drugs for therapy and prophylaxis of thromboembolic conditions. Despite the limitation of their... 
VITAMIN-K EPOXIDE | COMPLEX SUBUNIT-1 VKORC1 | GENETIC POLYMORPHISMS | DRUG-INTERACTIONS | REDUCTASE COMPLEX | WARFARIN DOSE REQUIREMENTS | GAMMA-CARBOXYLATION SYSTEM | CYTOCHROME P4502C9 POLYMORPHISMS | SITE-DIRECTED MUTAGENESIS | warfarin | genotype | CYP2C9 | IN-VITRO | VKORCI | PERIPHERAL VASCULAR DISEASE | phenprocoumon | acenocoumarol | HEMATOLOGY
Journal Article
Journal of Neural Transmission, ISSN 0300-9564, 2018, Volume 126, Issue 1, pp. 5 - 18
Common polymorphisms in the genes encoding CYP2D6, CYP2C19, CYP2C9 and VKORC1 enzymes have an important role in predicting the occurrence of adverse effects... 
Phenoconversion | VKORC1 | CYP2C9 | CYP2D6 | Actionable | Pharmacogenomic | CYP2C19 | POLYMORPHISM | INDUCTION | CANCER | NEUROSCIENCES | CLINICAL NEUROLOGY | CYTOCHROME-P450 2D6 | IMPLEMENTATION CONSORTIUM GUIDELINES | INHIBITION | THERAPY | PHARMACOKINETICS | UPDATE | INTERETHNIC VARIABILITY | Pharmacogenetics | Genetic aspects | Analysis | Genes | Genetic polymorphisms | Cytochrome P-450
Journal Article
PHARMACOGENOMICS, ISSN 1462-2416, 2014, Volume 15, Issue 13, pp. 1717 - 1722
The CYP2C9 c.449G>A (p.R150H, rs7900194) polymorphism, which confers the CYP2C9*8 allele, is common in persons of African descent and results in reduced... 
GENOTYPES | CYP2C9 | GENETIC POLYMORPHISMS | CYP2C98 | genotyping | pyrosequencing | RISK | PHARMACOLOGY & PHARMACY | CYP2C9-1766T > C | warfarin | Genotype | Polymorphism, Single Nucleotide | Sequence Analysis, DNA | Humans | Alleles | Cytochrome P-450 CYP2C9 - genetics
Journal Article
Clinical and Experimental Pharmacology and Physiology, ISSN 0305-1870, 12/2017, Volume 44, Issue 12, pp. 1171 - 1179
Journal Article
Journal Article